Borealis Biosciences

About:

Borealis Biosciences is a company in the field of next-generation RNA medicines.

Top Investors: Novartis, Versant Ventures

Description:

Borealis Biosciences is a company in the field of next-generation RNA medicines, specializing in molecular and cellular biology, vivarium space, chemistry, and analytical capabilities.

Total Funding Amount:

$150M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2024-01-01

Founders:

David Powell

Number of Employees:

11-50

Last Funding Date:

2024-08-22

IPO Status:

Private

Industries: